AstraZeneca chief links Europe's Covid surge to rejection of firm's vaccine

Pascal Soriot says heightened T-cell immunity from Oxford jab may give more durable protection Coronavirus - latest updates See all our coronavirus coverage A decision not to use AstraZeneca's Covid-19 vaccine for elderly people in some European countries could help explain why the virus is currently triggering such high levels of infections in mainland Europe, the company's chief executive has said. Pascal Soriot told BBC Radio 4's Today programme that heightened T-cell immunity could be giving...